The influence of antibiotics on transitory resistome during gut colonization with CTX-M-15 and OXA-162 producing Klebsiella pneumoniae ST15.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 03 2021
Historique:
received: 23 11 2020
accepted: 16 02 2021
entrez: 19 3 2021
pubmed: 20 3 2021
medline: 13 10 2021
Statut: epublish

Résumé

Great efforts have been made to limit the transmission of carbapenemase-producing Enterobacteriaceae (CPE), however, the intestinal reservoir of these strains and its modulation by various antibiotics remain largely unexplored. Our aim was to assess the effects of antibiotic administration (ampicillin, ceftazidime, ciprofloxacin) on the establishment and elimination of intestinal colonization with a CTX-M-15 ESBL and OXA-162 carbapenemase producing Klebsiella pneumoniae ST15 (KP5825) in a murine (C57BL/6 male mice) model. Whole genome sequencing of KP5825 strain was performed on an Illumina MiSeq platform. Conjugation assays were carried out by broth mating method. In colonization experiments, 5 × 10

Identifiants

pubmed: 33737655
doi: 10.1038/s41598-021-85766-6
pii: 10.1038/s41598-021-85766-6
pmc: PMC7973416
doi:

Substances chimiques

Anti-Bacterial Agents 0
beta-Lactamases EC 3.5.2.6
oxacillinase EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6335

Références

J Enzyme Inhib Med Chem. 2013 Oct;28(5):990-6
pubmed: 22845331
Drugs. 2018 Apr;78(6):675-692
pubmed: 29671219
PLoS Pathog. 2015 Sep 03;11(9):e1005132
pubmed: 26334306
Antimicrob Agents Chemother. 2011 Jun;55(6):2585-9
pubmed: 21422202
Antimicrob Agents Chemother. 2013 Jan;57(1):674-6
pubmed: 23114767
Antibiotics (Basel). 2020 Feb 05;9(2):
pubmed: 32033322
J Antimicrob Chemother. 2018 Nov 1;73(11):3170-3175
pubmed: 30099490
J Travel Med. 2017 Apr 01;24(suppl_1):S44-S51
pubmed: 28521000
Clin Microbiol Rev. 2019 Nov 13;33(1):
pubmed: 31722889
Open Forum Infect Dis. 2018 Jun 28;5(7):ofy150
pubmed: 30046639
Ann Epidemiol. 2016 May;26(5):342-7
pubmed: 26994507
BMC Infect Dis. 2014 Jun 02;14:298
pubmed: 24889720
Scand J Infect Dis. 2014 Apr;46(4):320-4
pubmed: 24552581
Antimicrob Agents Chemother. 2014;58(1):467-71
pubmed: 24189247
FEMS Microbiol Lett. 2011 Nov;324(2):111-6
pubmed: 22092811
Animals (Basel). 2020 Jul 02;10(7):
pubmed: 32630808
Antimicrob Agents Chemother. 2012 Apr;56(4):2125-8
pubmed: 22290940
Antimicrob Agents Chemother. 2018 Nov 26;62(12):
pubmed: 30249690
Infect Control Hosp Epidemiol. 2016 Oct;37(10):1219-25
pubmed: 27452597
Microb Drug Resist. 2018 Oct;24(8):1207-1209
pubmed: 29473791
Biochem Pharmacol. 2017 Jun 15;134:114-126
pubmed: 27641814
Infect Control Hosp Epidemiol. 2018 May;39(5):584-589
pubmed: 29485018
Antimicrob Agents Chemother. 2010 Mar;54(3):1369-73
pubmed: 20086157
Clin Microbiol Infect. 2014 Sep;20(9):821-30
pubmed: 24930781
Infect Control Hosp Epidemiol. 2017 Oct;38(10):1209-1215
pubmed: 28758612
Clin Microbiol Rev. 2013 Oct;26(4):744-58
pubmed: 24092853
Antimicrob Agents Chemother. 2014 Oct;58(10):6139-44
pubmed: 25092712
Drugs. 2019 Sep;79(14):1529-1541
pubmed: 31407238
Clin Infect Dis. 2017 Jul 15;65(2):208-215
pubmed: 28369261
EClinicalMedicine. 2019 Oct 17;15:72-79
pubmed: 31709416
Antimicrob Resist Infect Control. 2017 Nov 15;6:113
pubmed: 29163939
Clin Microbiol Infect. 2000 Sep;6(9):509-15
pubmed: 11168187
Antimicrob Resist Infect Control. 2018 Jul 31;7:93
pubmed: 30083312
BMC Infect Dis. 2015 Apr 01;15:168
pubmed: 25887288
J Glob Antimicrob Resist. 2018 Dec;15:215-218
pubmed: 30393155
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
PLoS One. 2015 May 01;10(5):e0123063
pubmed: 25933288
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30323046
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Hosp Infect. 2016 Sep;94(1):54-9
pubmed: 27392978
Antimicrob Agents Chemother. 2012 Jan;56(1):559-62
pubmed: 22083465
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1862-4
pubmed: 26666930
BMC Biol. 2019 Sep 18;17(1):76
pubmed: 31533707
Lancet Infect Dis. 2017 Feb;17(2):153-163
pubmed: 27866944
Am J Infect Control. 2016 May 1;44(5):539-43
pubmed: 26899297

Auteurs

Balázs Stercz (B)

Institute of Medical Microbiology, Semmelweis University, Nagyvárad tér 4., 1089, Budapest, Hungary.

Ferenc B Farkas (FB)

Institute of Medical Microbiology, Semmelweis University, Nagyvárad tér 4., 1089, Budapest, Hungary.

Ákos Tóth (Á)

Department of Bacteriology, Mycology and Parasitology, National Public Health Centre, Albert Flórián út 2-6., 1097, Budapest, Hungary.

Márió Gajdács (M)

Institute of Medical Microbiology, Semmelweis University, Nagyvárad tér 4., 1089, Budapest, Hungary.
Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Eötvös utca 6., 6720, Szeged, Hungary.

Judit Domokos (J)

Institute of Medical Microbiology, Semmelweis University, Nagyvárad tér 4., 1089, Budapest, Hungary.

Viola Horváth (V)

Department of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics, Szent Gellért tér 4., 1111, Budapest, Hungary.
MTA-BME Computation Driven Chemistry Research Group, Szent Gellért tér 4., 1111, Budapest, Hungary.

Eszter Ostorházi (E)

Institute of Medical Microbiology, Semmelweis University, Nagyvárad tér 4., 1089, Budapest, Hungary.

Nóra Makra (N)

Institute of Medical Microbiology, Semmelweis University, Nagyvárad tér 4., 1089, Budapest, Hungary.

Béla Kocsis (B)

Institute of Medical Microbiology, Semmelweis University, Nagyvárad tér 4., 1089, Budapest, Hungary.

János Juhász (J)

Faculty of Information Technology and Bionics, Péter Pázmány Catholic University, Práter utca 50/A., 1083, Budapest, Hungary.

Balázs Ligeti (B)

Faculty of Information Technology and Bionics, Péter Pázmány Catholic University, Práter utca 50/A., 1083, Budapest, Hungary.

Sándor Pongor (S)

Faculty of Information Technology and Bionics, Péter Pázmány Catholic University, Práter utca 50/A., 1083, Budapest, Hungary.

Dóra Szabó (D)

Institute of Medical Microbiology, Semmelweis University, Nagyvárad tér 4., 1089, Budapest, Hungary. szabo.dora@med.semmelweis-univ.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH